Laurus Labs Limited

Rentabilité sur six mois: +10.2%
Rendement en dividendes: 0.2555%

599 ₹

+4.1 ₹ +0.6892%
419.6 ₹
651.65 ₹

paper.min_max_per_year

Calendrier des promotions Laurus Labs Limited

À propos de l'entreprise Laurus Labs Limited

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs.

plus de détails
In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Paramètres de base

ISIN
INE947Q01028
Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Валюта отчета
inr
Див.доход ао
0.263
Дивиденд ао
0.8
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 4.47 4
P/BV 5.44 2
P/E 139.4 1
Efficacité
Nom Signification Grade
ROA 1.91 1
ROE 3.91 1
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0.2555 0.65
DSI 0.8571 8.57
Croissance moyenne du dividende 9.88 10
Devoir
Nom Signification Grade
Debt/EBITDA 1.57 7
Debt/Ratio 0.2989 10
Debt/Equity 1.04 8
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 76.63 8
Rentabilité Ebitda, % 188.31 10
Rentabilité EPS, % -15.58 0

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 594.9 ₹ 0 ₹ 0 ₹ 0.69 % 0 % 0 %
common.calendar.number_days.7d 593.35 ₹ 0 ₹ 0 ₹ 0.95 % 0 % 0 %
common.calendar.number_days.30d 625.4 ₹ 590.5 ₹ 608.3 ₹ -4.22 % 0 % 0 %
common.calendar.number_days.90d 550.05 ₹ 560.5 ₹ 651.65 ₹ 8.9 % 0 % 0 %
common.calendar.number_days.180d 543.55 ₹ 510.55 ₹ 651.65 ₹ 10.2 % 0 % 0 %
common.calendar.number_days.1y 440.95 ₹ 419.6 ₹ 651.65 ₹ 35.84 % 0 % 0 %
common.calendar.number_days.3y 562.85 ₹ 289.65 ₹ 651.65 ₹ 6.42 % 0 % 0 %
common.calendar.number_days.5y 468.9 ₹ 259.5 ₹ 1 493.6 ₹ 27.75 % 0 % 0 %
common.calendar.number_days.10y 0 ₹ 259.5 ₹ 1 493.6 ₹ 0 % 0 % 0 %
common.calendar.number_days.ytd 571.35 ₹ 510.55 ₹ 651.65 ₹ 4.84 % 0 % 0 %

Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Dr. Satyanarayana Chava M.Sc., Ph.D. CEO & Whole Time Director 186.44M 1961 (64 année)
Mr. Vantaram Venkata Ravi Kumar Dip in Mgmt., DIS, F.C.M.A. CFO & Whole-Time Director 49.65M 1965 (60 années)
Mr. B. V. R. K. Suryadevara Srinivasa Rao Executive Vice President of Manufacturing & Operations N/A 1968 (57 années)
Mr. Narasimha Rao Chava Executive Vice President of Human Resources N/A 1968 (57 années)
Dr. Lakshmana Rao Venkata Chunduru M.Sc., Ph.D. Head of Quality & Executive Director 33M 1962 (63 année)
Mr. Srinivasa Rao Suryadevara B.Sc, M.Sc. Executive Vice President of Manufacturing N/A 1963 (62 année)
Mr. Chagarlamudi Sita Ramaiah Executive Vice President of Finance N/A 1973 (52 année)
Mr. Dammalapati Venkata Lakshmi Narasimha Rao Executive Vice President of Synthesis N/A 1969 (56 années)
Mr. Krishna Chaitanya Chava Executive VP, Head of Synthesis & Ingredients and Executive Director N/A 1990 (35 années)
Mr. Rajaram Iyer M.B.A. Executive Vice President of Portfolio Management 1974 (51 année)

Informations sur l'entreprise

Adresse: India, Hyderabad, Serene Chambers - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.lauruslabs.com